Login / Signup

Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines.

Xuemei XieJangsoon LeeJon A FusonHuey LiuToshiaki IwaseKyuson YunCori MargainDebasish TripathyNaoto Tada Ueno
Published in: Biomedicines (2023)
Our data suggest a new strategy of combining eribulin with PI3K or mTOR inhibitors to treat TNBC.
Keyphrases
  • metastatic breast cancer
  • phase ii
  • electronic health record
  • cell proliferation
  • big data
  • tyrosine kinase
  • protein kinase
  • bioinformatics analysis
  • machine learning
  • artificial intelligence